Kidney Health Initiative (KHI)

KHI Mission

Kidney Health Initiative

To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.

KHI Activities during ASN 2014 Kidney Week

KHI's Open Workshop: "Standardized Pharmacokinetic Assessment in Patients Receiving Continuous Renal Replacement Therapy

The KHI workgroup responsible for writing a recommendation on pharmacokinetics in patients receiving Continuous Renal Replacement Therapy (CRRT) has completed their work. KHI is hosting an open workshop to review the recommendations and obtain feedback from the community. The workshop is scheduled for Tuesday, November 11 to coincide with ASN Kidney Week 2014.

Registration for the workshop is complimentary but required for our planning purposes as space is limited. Click here to register for the workshop. More information on the topics and speakers will be posted in late August.

KHI Open House

KHI will hold an Open House during Kidney Week to meet with prospective and current members on Friday, November 14 from 12:30PM – 2:00PM. Similar to 2013, the event will be a networking event with comments by the co-chairs. A light lunch will be provided.

KHI Project Portal Submissions

KHI seeks to advance its mission through innovative, collaborative projects that seek input from and bring together members across all areas of the kidney community.

We encourage KHI members to submit their ideas for projects via the KHI project portal, which is opened at various times throughout the year. If you are interested in submitting a proposal, please visit the Project Submission page.

Call for Workgroups

Starting in August 2013, KHI project concepts will be submitted by KHI members several times a year. At the close of each submission cycle, the KHI Board of Directors endorses projects after a simple review based on three criteria: meeting KHI mission, impact, and feasibility.

KHI workgroups will be selected via a small sub-group of the KHI Board of Directors. Click here to review the process for workgroup selection as well as the current selection sub-group.

Following is a list of current opportunities for KHI members to volunteer their service on a project workgroup. Click on the title for more information and details on how to volunteer.

Involvement in workgroups is on a voluntary basis with no compensation provided. All workgroup members are required to submit a disclosure with their application. Click here to review KHI's conflict of interest policy.

CJASN Special Feature

Press Release

Read the press release announcing the new partnership:

Watch the Video

ASN Executive Director Tod Ibrahim provides an update on the early success of the Kidney Health Initiative. Watch video »

ASN President Ronald Falk, MD, FASN discusses the Society's collaboration with the FDA. Watch video »

Listen to Podcasts

Announcing Kidney Health Initiative (KHI)

This Kidney News podcast features ASN Executive Director Tod Ibrahim's interview with ASN President Ronald J. Falk, MD, FASN, on the Kidney Health Initiative (KHI), a new partnership between ASN and the U.S. Food and Drug Administration to advance kidney health. Dr. Falk describes how KHI will collaborate with patient support groups, professional organizations, industry groups and other stakeholders to foster development of new therapeutics and ensure the safety of drugs, devices, biologics, and food products for patients with kidney disease. Posted September 27, 2012.

Kidney Health Initiative: Creating a Bright Future

Renal Support Network's KidneyTalk, "Kidney Health Initiative: Creating a Bright Future" with KHI co-chair Prabir Roy-Chaudhury, MD, PhD, FASN. Posted March 20, 2014.

Learn More

If you have any questions about KHI, or would like more information about becoming a member, please contact